NEUROLOGIX INC/DE

NEUROLOGIX INC/DE is a specialty pharmaceutical preparations company (SIC 2834) focused on developing and marketing injectable and oral therapeutic blends for chronic neurological and immune-mediated conditions. The firm sells directly to hospital pharmacy buyers, wholesale distributors, and specialty clinics that treat Parkinsonian syndromes and multiple sclerosis, while also partnering with larger biotech sponsors for co-development programs. Revenue derives from ongoing licensing agreements, contract manufacturing services, and proprietary product sales, but growth remains tied to obtaining regulatory clearances, protecting IP, and scaling manufacturing capacity within FDA oversight of active pharmaceutical ingredients and sterile compounding facilities. Investors should weigh the volatility in clinical trial advancement, the potential for adverse regulatory findings, and the dependence on a limited number of high-value contracts against the firm’s cash reserves. CIK 356591 shows a last filed Form 10-Q in May 1999, signaling a need to monitor any filings or restatements, and readers can view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025